Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xifeng Dingchan
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Henan University of Chinese Medicine
- Administration
- Oral
01
Overview
Xifeng Dingchan is a Traditional Chinese Medicine (TCM) formula developed for the treatment of Parkinson's disease. It is designed based on the TCM principle of tonifying the liver and kidney to extinguish wind and stop tremors. Research conducted by the First Affiliated Hospital of Henan University of Traditional Chinese Medicine suggests that the formula may exert neuroprotective effects by modulating the AMPK/SIRT3/GSK3β/LC3 signaling pathway. This pathway is involved in regulating autophagy and mitochondrial function in dopaminergic neurons, potentially slowing disease progression. It is typically used as an adjunctive therapy to standard treatments like levodopa to improve clinical efficacy and patient quality of life.
- Brand names
- Xifeng Dingchan Pill
- Other names
- Xifeng Dingchan PillXifeng Dingchan DecoctionXifeng Dingchan Granule
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)SIRT3 (NAD-dependent protein deacetylase sirtuin-3)GSK3 (Glycogen synthase kinase 3 beta)LC3 (Microtubule-associated proteins 1A/1B light chain 3B)
Beyond the preview
Go deeper on Xifeng Dingchan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xifeng Dingchan.